Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive congenital disorder affecting multiple systems with features of a ciliopathy. Affected individuals typically have some type of intestinal atresia, variable ocular abnormalities, microcephaly, and sometimes involvement of other systems, including renal and cardiac. In some cases, the condition is lethal in early life, whereas other patients show normal survival with or without mild cognitive impairment (summary by Filges et al., 2016).
Features include rarely findings: Accessory spleen and Preaxial polydactyly. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Retinal vascular tortuosity, Cataract, Optic nerve hypoplasia |
Digestive system | 2 | Accessory spleen, Intestinal malrotation |
Head and neck | 2 | Cleft palate, Microcephaly |
Muscles | 1 | Myopathy |
Brain and nerves | 1 | Hydrocephalus |
Kidneys and urinary system | 1 | Bilateral renal hypoplasia |
Initially believed to be pathognomonic of Strmme syndrome, small intestine atresia is now considered a distinctive but nonobligatory feature. A highly variable clinical presentation is observed among affected individuals that may range from mid-gestation lethality, to multisystem involvement with features implicated in the ciliopathies, to nonsyndromic microcephaly with developmental delay. To date, at least 26 individuals have been identified with pathogenic variants in CENPF [, , , , , , , , , , , , , ]. The following description of the phenotypic features associated with Strmme syndrome is based on 25 individuals with clinical descriptions from these reports. Table 2. Strmme Syndrome: Frequency of Select Features
Feature | Proportion of Persons w/Feature | Comment |
|---|---|---|
Intestinal atresia | Small bowel intestinal atresia | 14/25 |
Neurodevelopmental |
CENPF encodes centromere protein F (3,114 aa). Required for kinetochore function and chromosome segregation in mitosis. Required for kinetochore localization of dynein, LIS1, NDE1 and NDEL1. Highest expression in Cells EBV-transformed lymphocytes (34.6 TPM) and Cells Cultured fibroblasts (16.9 TPM).
Stromme syndrome is associated with mutations in the CENPF gene on chromosome 1.
The CENPF protein participates in FOXM1 stimulates CENPF transcription and p-T611,S730,S739-FOXM1:CENPF Gene pathways.
CENPF is classified as a druggable target with score 0.0.
No genotype-phenotype correlations have been identified.
Source: GeneReviews — "Strmme Syndrome"
No consensus clinical diagnostic criteria for Strmme syndrome have been published.
Strmme syndrome should be suspected in individuals with the following clinical, imaging, and family history findings.
Clinical findings
Small bowel intestinal atresia, in particular apple peel intestinal atresia
Microcephaly
Mild-to-moderate developmental delay and/or intellectual disability
Various ocular anomalies including anterior segment anomalies and microphthalmia
Genitourinary anomalies including hypoplastic kidney, horseshoe kidney, hydroureteronephrosis, and/or cryptorchidism
Imaging findings
Source: GeneReviews — "Strmme Syndrome"
Strmme syndrome. Because Strmme syndrome is associated with a highly variable clinical presentation, phenotypic features are often not sufficient to diagnose the condition. All disorders that fall within the spectrum of ciliopathies should be considered in the differential diagnosis. Intestinal atresia. Syndromes of interest in the differential diagnosis of intestinal atresia are summarized in . Table 3. Genes of Interest in the Differential Diagnosis of Intestinal Atresia
Gene | Disorder | MOI | Distinctive Features |
|---|---|---|---|
MYCN | Feingold syndrome 1 (FS1) | AD | Unlike Strmme syndrome, FS1 is assoc w/:; Digital anomalies incl toe syndactyly, thumb hypoplasia, brachymesophalangy;; Tracheoesophageal atresia. |
Genetic testing for CENPF is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Stromme syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for Strmme syndrome have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with Strmme syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Strmme Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Feeding | Gastroenterologist/ GI surgeon/ nutrition/ feeding team eval | To incl eval of intestinal atresia feeding difficulties |
Neurologic | Neurologic eval | Consider brain MRI to delineate structural brain anomalies if there is evidence of neurologic abnormalities or DD. |
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech/language eval; Eval for early intervention/ special education |
Ophthalmologic | Ophthalmologic exam | To assess for structural eye anomalies visual impairment Genitourinary anomalies |
heart disease | Echocardiogram | To assess valvular anatomic defects Genetic |
Source: GeneReviews — "Strmme Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Strmme Syndrome"
View trials for Stromme syndrome
Table 6.
Recommended Surveillance for Individuals with Strmme Syndrome
System/Concern | Evaluation | Frequency
|
Measurement of growth parameters
Eval of nutritional status oral intake
| At each visit
| Monitor developmental progress educational needs.
| Eval of structural eye anomalies | Per treating ophthalmologist
Evaluate for changes in vision. | Per low-vision clinic
Family/
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit
Source: GeneReviews — "Strmme Syndrome"
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Stromme syndrome.
2 publications have been identified in PubMed for Stromme syndrome. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Xiong Y (2025). [PMID: 40044674](https://pubmed.ncbi.nlm.nih.gov/40044674/). *Oncogenesis*. [Basic Science / Preclinical]
Al Mutairi F (2024). [PMID: 39166056](https://pubmed.ncbi.nlm.nih.gov/39166056/). *Heliyon*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 8:42 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Stromme syndrome
Microcephaly |
21/23 |
Developmental delay/ intellectual disability | 13/14 | — |
Structural brain anomalies | 9/15 | Corpus callosum agenesis, hydrocephalus, pachygyria, lissencephaly, holoprosencephaly, cerebral cerebellar hypoplasia |
Ophthalmologic | Anterior segment anomalies | 9/14 |
Microphthalmia | 8/14 | Unilateral or bilateral |
Genitourinary anomalies | Hypoplastic kidney | 6/16 |
Cryptorchidism | 4/9 | — |
Other | Congenital heart disease | 5/182 |
Polydactyly | 2/25 | Preaxial |
Accessory spleen | 2/11 | Three of the individuals with intestinal atresia reported in the literature did not have the affected segment specified and are therefore excluded from the denominator. 2. Physiologic patent ductus arteriosus due to prematurity is not included. Small bowel atresia. |
Source: GeneReviews — "Strmme Syndrome"
PI4KA |
PI4KA-related multiple intestinal atresia ± immunodeficiency (See PI4KA-Related Disorder.) |
AR |
Unlike Strmme syndrome, PI4KA-related disorder may be assoc w/immunodeficiency. |
RFX6 | Mitchell-Riley syndrome (OMIM 615710) | AR | Unlike Strmme syndrome, Mitchell-Riley syndrome is assoc w/:; GI involvement incl cholestasis, gallbladder aplasia or hypoplasia, hypoplastic or annular pancreas;; Neonatal or childhood onset diabetes. |
TTC7A | Gastrointestinal defects immunodeficiency syndrome 1 (GIDID1) (OMIM 243150) | AR | Unlike Strmme syndrome, GIDID1 is assoc w/:; GI involvement (e.g., hepatitis, omphalocele);; Immunodeficiency w/thymus hypoplasia. AD = autosomal dominant; AR = autosomal recessive; GI = gastrointestinal; MOI = mode of inheritance |
Source: GeneReviews — "Strmme Syndrome"
counseling |
By genetics professionals1 |
To inform affected persons their families re nature, MOI, implications of Strmme syndrome to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with Strmme Syndrome Manifestation/Concern | Treatment | Considerations/Other |
Intestinal atresia | Surgical treatment of gastrointestinal atresia | Per gastroenterologist/ GI surgeon Developmental delay/ |
Intellectual disability | See . | — |
Ophthalmologic | Per ophthalmologist | — |
Renal anomalies | Per renal consultants | — |
Cardiac anomalies | Per cardiac consultants | Family/Community |